Rocket Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.868; its P/E ratio is -7.89; Rocket Pharmaceuticals is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.71. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	$ -600.00K	$ -700.00K	$ -500.00K	$ 400.00K	$ 500.00K
EBIT	$ -61.58M	$ -61.43M	$ -65.23M	$ -59.77M	$ -68.00M
EBITDA	$ -59.87M	-	$ -64.03M	$ -62.19M	$ -69.08M
Net Income Common Stockholders	$ -62.05M	$ -61.90M	$ -65.70M	$ -58.34M	$ -66.72M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 330.31M	$ 437.17M	$ 307.04M	$ 331.08M	$ 356.39M
Total Assets	$ 499.44M	$ 598.76M	$ 461.78M	$ 514.76M	$ 551.81M
Total Debt	$ 25.95M	$ 25.18M	$ 25.39M	$ 25.40M	$ 22.87M
Net Debt	$ -304.36M	$ -411.99M	$ -281.65M	$ -305.69M	$ -333.53M
Total Liabilities	$ 57.94M	$ 57.68M	$ 58.81M	$ 55.88M	$ 62.12M
Stockholders Equity	$ 441.50M	$ 541.09M	$ 402.97M	$ 458.88M	$ 489.69M
Cash Flow	-
Free Cash Flow	$ -58.89M	-	$ -54.98M	$ -60.61M	$ -59.02M
Operating Cash Flow	$ -56.86M	$ -57.15M	$ -50.86M	$ -57.59M	$ -56.02M
Investing Cash Flow	$ 35.03M	$ 48.25M	$ 31.21M	$ -36.72M	$ -108.58M
Financing Cash Flow	$ 1.18M	$ 189.49M	$ 182.00K	$ 18.34M	$ 108.44M

Currency in USD

Rocket Pharmaceuticals Earnings and Revenue History

Income Statement >

Rocket Pharmaceuticals Debt to Assets

Balance Sheet >

Rocket Pharmaceuticals Cash Flow

Cash Flow >

Rocket Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing